“The Automated Liquid Handling (ALH) Technologies market is projected at USD 1.98 billion in 2020”, says Visiongain

31 October 2019
Pharma

Automated Liquid Handling (ALH) Technologies Market Forecast 2020-2030: Forecasts and Analysis by Type (Multipurpose Workstation, Pipetting Workstation, Specialized Liquid Handler, Workstation Module), By End User, By Procedure (Serial Dilution, Plate Reformatting, Plate Replication, PCR Setup, High-Throughput Screening, Cell Culture, Whole Genome Amplification,Array Printing) and Geography, with Profiles of Leading Companies, with Profiles of Leading Companies report provides impartial Automated Liquid Handling (ALH) Technologies sector analysis.

According to the report published by Visiongain, the Automated Liquid Handling (ALH) Technologies market is projected at USD 1.98 billion in 2020. It is projected that a CAGR of 9.4 times will be recorded during the 2020-2030 forecast period. It is anticipated that the industry will fuel the introduction of new integrated liquid processing workstations for non-contact dispensing.

Automated Liquid Handling (ALH) Technologies Market is witnessing Growth due to factors such as

Automated liquid processing devices vary from multi-channel semi-automated pipettors to room-sized devices. The sector is moving in the direction of flexible, flexible ALH systems— apparently for every expenditure. Likewise, the tendency towards higher customer accessibility was accompanied by instrumentation, software, and techniques. Automated liquid handlers arrive with many distinct requirements in a seemingly infinite multitude of settings. An significant consideration is what minimum or peak amount of dispensing is right for your procedures. If your sample quantity is extremely variable, it is worth contemplating having a more solid facility that can dispense low-range and high-range quantity.

The use of liquid-filled integrated liquid treatment devices with reusable set advice for sample processing of bioanalytical assays has several benefits. However, unoptimized liquid handling parameters may result in sample dilution by the automatic liquid handler's device liquid creating probable sample shipping inaccuracy. In this inquiry, specimen distribution liquid handling parameters such as aspiration velocity, dispensation velocity, separation quantity, surplus quantity, and water spaces were carefully examined to know their functions in precise specimen shipment. Consequently, two strategies for optimization of the parameters are presented that achieve accurate sample delivery while maintaining sample integrity.

Automated liquid treatment (ALH) devices are commonly used in a wide spectrum of apps for the shipment of liquid samples, such as high-throughput screening in drug discovery and development studies, and body fluid imaging assays. For bioanalytical techniques used in metabolism and pharmacokinetic research, ALH schemes are also used to move biological samples, handle normal graphs and quality control (QC) specimens, and conduct serial sample dilutions. The sample's quality and shipping precision are essential for bioanalytical assays with rigorous quantitative demandsHowever, an inquiry into the performance of an ALH scheme run with set hints by photometrically and gravimetrically evaluating the dispensed quantities reveals that there was a substantial distinction between the outcomes achieved through the two methods to evaluating quantities. This distinction was ascribed to the dilution by the ALH scheme liquid of the sample supplied quantity when using the standard parameter for liquid handling (LHP) environments.

 Shift in Trends

Manufacturers are creating workstations depending on various surface-free dispensing techniques. These techniques include ultrasound, solenoid, and piezoelectric. For example, LABCYTE INC. utilizes Echo's acoustic liquid processing technology to deliver non-contact dispensing in its products. In addition, effective miniaturization of assay platforms reduces workflow expenditure by reduction in use of expensive reagents. Increasing development of acoustic liquid handling platforms, which enable faster processing, is likely to stoke the growth of the market. Growing trend of automation and advantages of automated liquid handling over manual handling are also providing a fillip to the market. Due to its accuracy, convenience, and small price, touch dispensing has achieved broad recognition over the years. However, the need for liquid processing is noted to change with sample quantity decrease. Surface adhesion is the most prominent variable affecting the efficiency of liquid processing in the sample size from pre to nanoliter.

The industry was divided into autonomous liquid processing workstations and reagents and consumables based on the item. Based on their installation and form, workstations were evaluated. They can be segmented into stand-alone and embedded workstations depending on installation and can be split into multipurpose, pipetting, dedicated liquid handlers, and workstation module depending on sort.

Growing rivalry among pharmaceutical companies is fueling the implementation of robotic workstations and their quest of developing novel drugs. Small footprint and the capacity to deliver precise serial dilution and slice replication, as well as quicker, contribute to greater market penetration. Some of the common pipettors available in the market are Biotek’s Precision XS, Agilent’s Bravo, Beckman Coulter’s Biomek NX, Agilent’s Vprep, Hamilton’s NIMBUS, and TTP Labtech mosquito HTS. Consumables expense pharmaceutical companies & biotech labs considerably. Higher consumer prices together with recurrent use of these products in workflow measures play a crucial part in the development of the section of reagents and consumables. However, it is estimated that growing numbers of third-party suppliers for disposable advice compliant with robotic devices will decrease their acceptance of standard equipment over the years.

In a single drug discovery experiment, more than one million compounds are tested to define fresh drug candidates. Various drug discovery & ADME Tox apps include step-by-step simultaneous dilution across broad dose ranges, re-test choice and transition of compounds, and confirmatory & further evaluation. The drug discovery and ADME Tox section is positioned throughout the forecast period to constitute the major position in the industry for integrated liquid processing techniques. The main benefits connected with the use of autonomous liquid processing systems in drug discovery are the ability to incorporate distinct kinds of liquid handlers and stackers or incubators for improving throughput.

Automated liquid processing is an important component of cancer and genomic studies as it needs protein or DNA solutions to be delivered to substrates or microwells. Usually subsequent measures incorporating synthesis and evaluation involve extra alternatives to be provided. It becomes impractical and tedious to use basic liquid processing methods for these measures. For genomics and cancer research, the adoption of robotic liquid processing techniques is expected to experience significant development in the coming years.

Regional Market Analysis

Due to the well-established delivery network of significant market players and the increased use of sophisticated automation alternatives, North America was at the heart of the industry in 2019. Life science study demand for tiny quantity genomics and proteomics assessment further stimulates national market growth. Competitors in the region are working to boost their income with big scholarly universities and study centres in Europe. However, expanding local biotech firms presence, increasing financing assistance, and regulation of the CFDA in China and price reform in Japan (influencing both off-patent and patent products) are probable to promote the biopharmaceutical industry's advancement. It is estimated that rapid advancement by biopharmaceutical & robotics firms as well as project organisations in nations such as Japan and China will boost the Asia Pacific industry. During the forecast period, the region is able to display the greatest CAGR.

Competition in the market

Because of their fast acceptance by pharma & biopharma CROs, multipurpose workstations are expected to experience the highest development over the prediction era. These workstations allow the washing of microplate, multichannel pipetting and the dispensing of bulk reagents within a single unit. Cancer & genomic study is set to see the highest development due to the capacity of automatic fluid processing devices to manage various microliter specimens to the quantity of picoliter. The difficulty of the workflow and the need for quicker destination testing result in the pharmaceutical & biology firms increasing the setup of an integrated workstation.

Due to the existence of several main competitors, North America dominated the industry in 2019. Due to favorable growth factors for pharmaceutical and biopharmaceutical businesses in the region, Asia Pacific is anticipated to record the largest CAGR during the forecast period. Increasing investment in the life sciences, medicine and pharmaceutical industries also contributes to national market growth. Agilent Technologies; Labcyte Inc.; Beckman Coulter, Inc., Aurora Biomed Inc.; Eppendorf AG; Hamilton Company; Gilson, Inc., Analytik Jena AG; and BioTek Instruments, Inc.

Competitors are engaged with biotech firms in global alliances to create assays & instruments to provide biopharmaceutical businesses with integrated workflows. Hamilton Robotics, for example, partnered with WATERS in June 2018 to develop STARWorks for sample training workflows using the assays of WATER-Waters ProteinWorks and Waters GlycoWorks.

Automated liquid processing (ALH) is a laboratory tool scheme composed of instruments and machinery intended to automatically sample, mix and combine liquid samples in clinical and study environments. In the broad spectrum of life science apps, automation is embraced, varying from genomics & proteomics to system engineering. It is used extensively in the industry for clinical diagnostics accompanied by study environments.

The worldwide ALH industry is influenced by advances in ALH systems-related technological advances, dearth in qualified experts, and benefits of ALH solutions over automatic pipetting. In addition, rise in awareness of the benefits of using ALH is expected to fuel the market growth.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Global Human Microbiome Therapeutics market set to grow to $1.6bn” by 2025 says new Visiongain report

The market for microbiome therapeutics is expected to commence around mid-2020 with the launch of new products relating to dermatology and gastrointestinal disorders.

04 December 2019

Read

“Global Next-Generation Biologics market set to grow to $42bn by 2024” says new Visiongain report

Technological developments in the next-generation biologics market will be the result of clinical development of multiple platforms in the next-generation antibody, antibody fragment and ALP sectors.

04 December 2019

Read

“Global Liquid Biopsy market set to grow to $4.9bn by 2024” says new Visiongain report

The main drivers for the growth include technological advancements such as development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

04 December 2019

Read

“Global nucleic acid isolation and purification market is anticipated to reach USD 8.16 Billion by 2030”, says Visiongain

Nucleic acid separation and purification is one of modern science and technology’s most complex and critical accomplishments.

29 November 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever